Inhalt

Originalarbeiten 2014/2015

  • Niebauer J, Mayr K, Harpf H, Hofmann P, Müller E, Wonisch M, Pokan R, Benzer W. Long-term effects of outpatient cardiac rehabilitation in Austria: a nationwide registry. Wien Klein Wochenschr 2014, 126:148-155.
  • Mühlberger V, Kaltenbach J, Kobel C, Pachinger O, im Auftrag der Datenverantwortlichen aller österreichischen Herzkatheterzentren. Herzkathetereingriffe in Österreich im Jahr 2012 (mit Audit bis 2013). J Kardiol 2014, 21:3-4_Online.
  • Mühlberger V, Kobel C, Kaltenbach J, Pachinger O. Austrian National CathLab Registry (ANCALAR): cardiac catherization, coronary angiography (CA), and percuatenous coronary intervention (PCI) in Austria during the year 2011 (Registry data with audit including 2012). Wien Klin Wochenschr 2013. 125:736-749..
  • Haiden A, Eber B, Weber T. U-shasped relationship of left ventricular ejection time index and all-cause mortality. Am J Hypert 2014, 27:doi:10.1093/ajh/hpt185: 702-709.
  • Lassnig E, Dinkhauser P, Maurer E, Eber B. Life-threatening heat shock presenting with ST elevations: a report of consecutive cases during the heat wave in Austria in July 2013. Wien Klin Wochenschr 2014, 126:491-494.
  • Fox K, Steg PG, Tardif JC, Tendera M, Ferrari R fort he SIGNIFY Investigators. Ivabradfine in stable coronary artery disease without clinical heart failure. N Engl J Med 2014, 371:1091-1099.
  • Hametner B, Wassertheurer S, Hughes AD, Parker KH, Weber T, Eber B. Reservoir and excess pressures predivt cardiovascular events in high-risk patients. International Journal of Cardiology 2014, 171:31-36.
  • Parragh S, Hametner B, Bachler M, Weber T, Eber B, Wassertheurer S. Non-invasive wave reflection quantification in patients with reduced ejection fraction. Physiol Meas 2015, 36:179-190.
  • Mühlberger V, Kaltenbach J, Ulmer H, Pachinger O, im Auftrag der Datenverantwortlichen aller österreichischen Herzkatheterzentren. Herzkathetereingriffe in Österreich im Jahr 2013 (mit Audit bis 2014). J Kardiol 2015, 22:1-2_Online.
  • Weber T, Wassertheurer S, Hametner B, Parragh S, Eber B. Noninvasive methods to assess pulse wave velocity: comparison with the invasive gold standard and relationship with organ damage. J Hypertens 2015, 33:
  • Parragh S, Hametner B, Bachler M, Weber T, Eber B, Wassertheurer S. Non-invasive wave reflection quantification in patients with reduced ejection fraction. Physiol Meas 2015, 36:179-190.
  • Mühlberger V, Kaltenbach J, Ulmer H, Pachinger O, im Auftrag der Datenverantwortlichen aller österreichischen Herzkatheterzentren. Herzkathetereingriffe in Österreich im Jahr 2013 (mit Audit bis 2014). J Kardiol 2015, 22:1-2_Online.
  • Weber T, Wassertheurer S, Hametner B, Parragh S, Eber B. Noninvasive methods to assess pulse wave velocity: comparison with the invasive gold standard and relationship with organ damage. J Hypertens 2015, 33:
  • Eber B, Eber M, Enayati S, Freund C, Fitscha P, Ludvik B, Pfeiffer K, Rieder A, Suppan M. ArterinR bei Hypercholesterinämie – neue Hoffnung in der Primärprävention und bei Statin-Unverträglichkeit? Academy News 2015, 15:1-11.
  • Weber T, Wassertheurer S, Hametner B, Parragh S, Eber B. Noninvasive methods to assess pulse wave velocity: comparison with the invasive gold standard and relationship with organ damage. Journal of Hypertension 2015, 33:1023-1031.
  • Parragh S, Hametner B, Bachler M, Kellermair J, Eber B, Wassertheurer S, Weber T. Determinants and covariates of central pressures and wave reflections in systolic heart failure. Intern J Cardiol 2015, 190:308-314.
  • Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzylla W, de Lucca P, ImKA, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM, fort he IMPROVE-IT Investigators. Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med 2015,
  • Healey JS, Glikson M, Neuzner J, Mabo P, Vinolas X, Kautzner J, O’Hara G, VanErven L, Gadler F, Pogue J, Appl U, Gilkerson J, Pochet T, Stein KM, Merkely B, Chrolavacius S, Meeks B, Foldesi C, Thibault B, Connolly SJ on behalf oft he Schokless IMPlant Evaluation (SIMPLE) Investigators. Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE). Lancet 2015, 385:785-791.
  • Fox K, Steg PG, Tardif JC, Tendera M, Ferrari on behalf oft he SIGNIFY Investigators. Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: an analysis from the SIGNIFY study. Eur Heart J 2015, 36:3291-3296.